Medication info
SRBD Tablet

SRBD Tablet

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tabletTripotassium Bismuth Dicitrate›200mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Light green rectangular film-coated tablet
Packaging
30 tablets per bottle, 300 tablets per bottle
Approval status
Active

MFDS item code 201604940 · Approved 2016.08.12

Summary

Main use
Treatment of acid-related disorders (such as gastric ulcers and gastritis); prevention of Mendelson syndrome before anesthesia
Who takes it
Adults
Adult dose
Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers Take 1 tablet twice daily, or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease Take 1 tablet twice daily or 2 tablets once daily at bedtime for 8 weeks. In patients with severe gastroesophageal reflux disease, the dose may be increased to 2 tablets 4 times daily. Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. Preanesthetic medication (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as gastric ulcers and gastritis); prevention of Mendelson syndrome before anesthesia

  • Gastric ulcer
  • gastritis
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcers
  • gastric ulcer due to non-steroidal anti-inflammatory drugs
  • duodenal ulcer due to non-steroidal anti-inflammatory drugs
View approved original text

This medication is used to treat gastrointestinal-related conditions such as gastric ulcers, gastritis, duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It can also be administered prior to anesthesia to prevent Mendelson syndrome, and it aids in the treatment of ulcers that may occur post-surgery. It is effective in managing gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to alleviate the symptoms of various gastrointestinal diseases and improve lesions.

How to take

Adult dose

Usually, take 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. Gastric and duodenal ulcers Take 1 tablet twice daily, or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by taking 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for the prevention of gastric and duodenal ulcers during long-term NSAID treatment. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease Take 1 tablet twice daily or 2 tablets once daily at bedtime for 8 weeks. In patients with severe gastroesophageal reflux disease, the dose may be increased to 2 tablets 4 times daily. Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. Preanesthetic medication (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the night before surgery.

Precautions

This drug should not be used in patients receiving dialysis or those with kidney function problems. It should also be avoided in patients with a history of allergic reactions to this drug or its components. Patients with a history of acute porphyrias should be cautious as this drug may worsen symptoms. It is recommended not to administer the drug to patients who have undergone upper gastrointestinal tract surgery, pregnant women, or those with a possibility of pregnancy, as well as to premature infants or newborns. Patients on a diet that restricts potassium intake should also avoid using this drug. Patients with liver dysfunction or a history of drug allergies, the elderly, or those with a history of kidney dysfunction should use this drug carefully. Caution is especially needed for those taking NSAIDs simultaneously, and regular health checks are necessary. This drug may hide the symptoms of stomach cancer; therefore, patients with gastric ulcers or newly arisen dyspeptic symptoms over middle age should confirm malignancy before use. Patients with Helicobacter pylori infection with gastric or duodenal ulcers should also undergo bacterial eradication treatment. Caution is needed for severely ill patients in intensive care units, patients with hypophosphatemia, or patients who have difficulty swallowing. Rarely, serious allergic reactions or skin rashes, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and neurological abnormalities may occur during the administration of this drug, so consult a doctor immediately if abnormal symptoms arise. It is advised not to use this drug for long periods and to check for treatment effects; substitute with another medication if necessary. Elderly patients or those with chronic pulmonary diseases or diabetes may have an increased risk of pneumonia, so caution is warranted. Avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This drug may interact with other medications, so it is important to inform your doctor or pharmacist about any other drugs being taken. It is safer not to use this drug for pregnant or breastfeeding women. Safety and efficacy have not been established in children, so its use is not recommended. In case of overdose, appropriate treatment such as vomiting or gastric lavage is needed and may be removed by dialysis. This drug may reduce gastric acid secretion, promoting bacterial growth in the stomach; therefore, ophthalmic examinations may be necessary for long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • hypoplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • increased AST
  • increased ALT
  • increased r-GTP
  • increased ALP
  • jaundiced hepatitis
  • non-jaundiced hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • spasms
  • agitation
  • insomnia
  • headache
  • feelings of heaviness in the head
  • malaise
  • anxiety
  • delirium
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • myotonic contractions
  • gynecomastia
  • hypersecretion of milk
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • mild erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is safe to store at room temperature between 1°C and 30°C. Proper storage helps maintain the medication's effectiveness for a long period.

Appearance and packaging

Appearance

Light green rectangular film-coated tablet

Package unit

30 tablets per bottle, 300 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.